These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11846503)

  • 21. AVID and COMET.
    Liebson PR; ;
    Prev Cardiol; 2003; 6(4):218-20. PubMed ID: 14605516
    [No Abstract]   [Full Text] [Related]  

  • 22. Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary).
    Rajput FS; Gnanasekeram H; Satwani S; Davenport JD; Gracely EJ; Gopalan R; Narula J
    Am J Cardiol; 2003 Jul; 92(2):218-21. PubMed ID: 12860230
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of beta-adrenergic blocking agents in treatment of heart failure].
    Witkowska M
    Pol Arch Med Wewn; 1999 Jan; 101(1):9-14. PubMed ID: 10592722
    [No Abstract]   [Full Text] [Related]  

  • 24. β-Blockers in diabetic patients with heart failure.
    Santulli G
    JAMA Intern Med; 2015 Apr; 175(4):657. PubMed ID: 25844751
    [No Abstract]   [Full Text] [Related]  

  • 25. β-Blockers in diabetic patients with heart failure--reply.
    Pasternak B; Svanström H; Hviid A
    JAMA Intern Med; 2015 Apr; 175(4):657. PubMed ID: 25844752
    [No Abstract]   [Full Text] [Related]  

  • 26. Current research on carvedilol in heart failure.
    Bobadilla RV
    Crit Care Nurse; 2002 Aug; 22(4):14, 16. PubMed ID: 12166050
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
    Goldstein S; Gottlieb SS
    J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta blockers and congestive heart failure.
    Movahed A
    Am Fam Physician; 2000 Dec; 62(11):2402-4. PubMed ID: 11130228
    [No Abstract]   [Full Text] [Related]  

  • 29. Are there clinically important differences between beta-blockers in heart failure?
    Cleland JG; Loh H; Windram J
    Heart Fail Clin; 2005 Apr; 1(1):57-66. PubMed ID: 17386834
    [No Abstract]   [Full Text] [Related]  

  • 30. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Hjalmarson A; Waagstein F
    Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544
    [No Abstract]   [Full Text] [Related]  

  • 31. Are there differences between vasodilating and nonvasodilating beta-blockers in patients with heart failure? Do patients with ischemic heart disease benefit to the same degree?
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Jun; 49(6):496, 571. PubMed ID: 10923546
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
    Bauman JL; Talbert RL
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-adrenergic receptor blockade in chronic heart failure.
    Bristow MR
    Circulation; 2000 Feb; 101(5):558-69. PubMed ID: 10662755
    [No Abstract]   [Full Text] [Related]  

  • 34. [Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Kawano S
    Nihon Rinsho; 2007 May; 65 Suppl 5():91-7. PubMed ID: 17571371
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta-blockade in chronic heart failure.
    De Boer RA; Van Veldhuisen DJ
    Circulation; 2001 Jun; 103(23):E118. PubMed ID: 11401950
    [No Abstract]   [Full Text] [Related]  

  • 36. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 37. Top heart failure drugs compared.
    Health News; 2003 Sep; 9(9):6-7. PubMed ID: 14584471
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beta-blocking drugs indicated in patients with heart failure].
    Voors AA; van Gilst WH; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2457-9. PubMed ID: 14708208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.